Hemophilia screening: Difference between revisions

Jump to navigation Jump to search
Turky Alkathery (talk | contribs)
Sabawoon Mirwais (talk | contribs)
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{Simrat}}
{{CMG}}; {{AE}} {{Simrat}}
==Overview==
==Overview==
[[Genetic counseling]] is recommended for hemophilia carrier families.  
Initial screening blood investigations for any child with suspected bleeding disorder include platelet count, prothrombin time (PT),  and activated partial thromboplastin time (aPTT). These tests reveal a prolonged aPTT with a normal platelet count and PT. Chorionic villous sampling at 11-14 weeks of gestation can be performed for the genetic diagnosis of hemophilia.
==Screening==
==Screening==
[[Genetic counseling]] is recommended in hemophilia carrier families. Genetic counselors provide information and support for carriers and their families, before they conceive a child, and after the unpredicted birth of a son with hemophilia.
*Initial screening blood investigations for any child with suspected bleeding disorder include platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT).
Hemophilia can be diagnosed before, during or after birth if there's a family history of the condition.
*Chorionic villous sampling at 11-14 weeks of gestation can be performed for the genetic diagnosis of hemophilia.
 
Several options are available to parents
If there's no family history of hemophilia, it's usually only diagnosed when a child begins to walk or crawl. They may experience joint bleeds or easy bruising.
Mild hemophilia may only be discovered later, usually after an injury or a dental or surgical procedure.
 
===Tests before pregnancy===
[[Genetic testing]] and counseling are available to help determine the risk of passing the condition onto a child.
This may involve testing a sample of your tissue or blood to look for signs of the genetic [[mutation]] that causes hemophilia.
===Tests during pregnancy===
If you become pregnant and have a history of hemophilia in your family, tests for the hemophilia [[gene]] can be carried out. These include:
*[[Chorionic villus sampling]] (CVS) - a small sample of the placenta is removed from the womb and tested for the hemophilia [[gene]], usually during weeks 11-14 of pregnancy
*[[Amniocentesis]] – a sample of amniotic fluid is taken for testing, usually during weeks 15-20 of pregnancy.
*PUBS (percutaneous umbilical blood sampling)- PUBS directly tests the blood of the unborn baby. It is done after the 20th week of pregnancy. The doctor takes blood from the umbilical vein which runs from the baby to the placenta. The test results are ready in just a few days. <ref>{{Cite web | title =NHS Hemophilia screening| url =http://www.nhs.uk/Conditions/Haemophilia/Pages/Diagnosis.aspx }}</ref>
There's a small risk of these procedures causing problems such as miscarriage or premature labour, so you may want to discuss this with the doctor in charge of your care.
 
===Tests after birth===
If hemophilia is suspected after your child has been born, a blood test can usually confirm the diagnosis. Blood from the umbilical cord can be tested at birth if there's a family history of hemophilia. A blood test will also be able to identify whether your child has hemophilia A or B, and how severe it is.
<ref>{{Cite web | title = Hog handbook Hemophilia screening| url =http://www.hog.org/handbook/article/1/3/testing-for-hemophilia }}</ref>


==References==
==References==

Revision as of 03:43, 13 January 2019

Hemophilia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemophilia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemophilia screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemophilia screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemophilia screening

CDC on Hemophilia screening

Hemophilia screening in the news

Blogs on Hemophilia screening

Directions to Hospitals Treating Hemophilia

Risk calculators and risk factors for Hemophilia screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Initial screening blood investigations for any child with suspected bleeding disorder include platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT). These tests reveal a prolonged aPTT with a normal platelet count and PT. Chorionic villous sampling at 11-14 weeks of gestation can be performed for the genetic diagnosis of hemophilia.

Screening

  • Initial screening blood investigations for any child with suspected bleeding disorder include platelet count, prothrombin time (PT), and activated partial thromboplastin time (aPTT).
  • Chorionic villous sampling at 11-14 weeks of gestation can be performed for the genetic diagnosis of hemophilia.

References

Template:WH Template:WS